Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

140 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Conditioning with treosulfan and fludarabine followed by allogeneic hematopoietic cell transplantation for high-risk hematologic malignancies.
Nemecek ER, Guthrie KA, Sorror ML, Wood BL, Doney KC, Hilger RA, Scott BL, Kovacsovics TJ, Maziarz RT, Woolfrey AE, Bedalov A, Sanders JE, Pagel JM, Sickle EJ, Witherspoon R, Flowers ME, Appelbaum FR, Deeg HJ. Nemecek ER, et al. Among authors: sorror ml. Biol Blood Marrow Transplant. 2011 Mar;17(3):341-50. doi: 10.1016/j.bbmt.2010.05.007. Epub 2010 May 26. Biol Blood Marrow Transplant. 2011. PMID: 20685259 Free PMC article. Clinical Trial.
Re: Twenty-year follow-up in patients with aplastic anemia given marrow grafts from HLA-identical siblings and randomized to receive methotrexate/cyclosporine or methotrexate alone for prevention of graft-versus-host disease.
Sorror ML, Leisenring W, Deeg HJ, Martin PJ, Storb R. Sorror ML, et al. Biol Blood Marrow Transplant. 2005 Jul;11(7):567-8. doi: 10.1016/j.bbmt.2005.03.004. Biol Blood Marrow Transplant. 2005. PMID: 15983557 Free article. Clinical Trial. No abstract available.
Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia.
Kerbauy DM, Chyou F, Gooley T, Sorror ML, Scott B, Pagel JM, Myerson D, Appelbaum FR, Storb R, Deeg HJ. Kerbauy DM, et al. Among authors: sorror ml. Biol Blood Marrow Transplant. 2005 Sep;11(9):713-20. doi: 10.1016/j.bbmt.2005.05.008. Biol Blood Marrow Transplant. 2005. PMID: 16125642 Free article.
Twenty-year follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia.
Sorror ML, Leisenring W, Deeg HJ, Martin PJ, Storb R. Sorror ML, et al. Biol Blood Marrow Transplant. 2005 Oct;11(10):814-5. doi: 10.1016/j.bbmt.2005.05.016. Biol Blood Marrow Transplant. 2005. PMID: 16182182 Free article. Clinical Trial. No abstract available.
Reduced incidence of acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimen.
Deeg HJ, Storer BE, Boeckh M, Martin PJ, McCune JS, Myerson D, Heimfeld S, Flowers ME, Anasetti C, Doney KC, Hansen JA, Kiem HP, Nash RA, O'Donnell PV, Radich JP, Sandmaier BM, Scott BL, Sorror ML, Warren EH, Witherspoon RP, Woolfrey A, Appelbaum FR, Storb R. Deeg HJ, et al. Among authors: sorror ml. Biol Blood Marrow Transplant. 2006 May;12(5):573-84. doi: 10.1016/j.bbmt.2005.12.036. Biol Blood Marrow Transplant. 2006. PMID: 16635793 Free article. Clinical Trial.
Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation.
Baron F, Storb R, Storer BE, Maris MB, Niederwieser D, Shizuru JA, Chauncey TR, Bruno B, Forman SJ, McSweeney PA, Maziarz RT, Pulsipher MA, Agura ED, Wade J, Sorror M, Maloney DG, Sandmaier BM. Baron F, et al. J Clin Oncol. 2006 Sep 1;24(25):4150-7. doi: 10.1200/JCO.2006.06.9914. Epub 2006 Aug 8. J Clin Oncol. 2006. PMID: 16896000
140 results